Antigene effect in K562 cells of a PEG-conjugated triplex-forming oligonucleotide targeted to the bcr/abl oncogene.
about
Site-specific mutagenesis by triple helix-forming oligonucleotides containing a reactive nucleoside analog.Effect of DNA target sequence on triplex formation by oligo-2'-deoxy- and 2'-O-methylribonucleotides.The potential for gene repair via triple helix formation.Synthesis and characterization of conformationally preorganized, (R)-diethylene glycol-containing γ-peptide nucleic acids with superior hybridization properties and water solubilityStabilization and photochemical regulation of antisense agents through PEGylation.Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation.The triple helix: 50 years later, the outcome.Covalent polymer-drug conjugates.Bioconjugation of oligonucleotides for treating liver fibrosis.DNA-polymer conjugates for immune stimulation through Toll-like receptor 9 mediated pathways.Targeting DNA base pair mismatch with artificial nucleobases. Advances and perspectives in triple helix strategy.Potential in vivo roles of nucleic acid triple-helices.Therapeutic oligonucleotides with polyethylene glycol modifications.Antiproliferative activity of a triplex-forming oligonucleotide recognizing a Ki-ras polypurine/polypyrimidine motif correlates with protein binding.Chemically defined polyethylene glycol siRNA conjugates with enhanced gene silencing effect.DNA meets synthetic polymers--highly versatile hybrid materials.Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
P2860
Q34910417-6FDF8AEF-6134-4649-91BC-FA5B2DF1BC00Q35164352-1030C68D-8C7B-41B6-B004-361C5A8653FAQ35202469-2A212178-0EB5-40F5-9450-3A0AA39D75BCQ35219222-D366CE7B-8359-4B5F-95CA-73B49B480B0CQ35514689-60E6E80D-EB1E-4644-B13F-73FFE6976161Q36715514-F37D22B3-CAA2-4A72-9C3A-A17C21EFBAA3Q36868459-4475D71E-9DB6-4EC4-8333-C480A039F47CQ37002669-2B9D2359-86FB-4FC2-97AA-1485C407FF3DQ37043515-F32D4FAE-8DF5-4E9D-B198-50F2B97BD2E9Q37589660-7D5678EC-45B5-406F-BDB7-D0DA4C4A06C9Q37806638-97FD4C45-186A-4816-BDDC-1E13405CC762Q37869778-25136C38-AB08-4B05-BB98-22F365205130Q38296021-1C247B39-B76F-4020-8319-9C3ECF1023C4Q38341878-6B77D420-6BB6-4F6A-9542-F730966703DAQ38868870-BB7D0211-6636-4E55-8850-B7A62DC14A25Q40140283-DB0E37B6-A251-484C-BD60-A2C199A04A69Q40191338-4DD011A3-9AC1-4FA4-A61C-9E6764FE8051Q46197118-D33958F7-8542-4F38-A10B-709E435CE88D
P2860
Antigene effect in K562 cells of a PEG-conjugated triplex-forming oligonucleotide targeted to the bcr/abl oncogene.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Antigene effect in K562 cells ...... geted to the bcr/abl oncogene.
@ast
Antigene effect in K562 cells ...... geted to the bcr/abl oncogene.
@en
type
label
Antigene effect in K562 cells ...... geted to the bcr/abl oncogene.
@ast
Antigene effect in K562 cells ...... geted to the bcr/abl oncogene.
@en
prefLabel
Antigene effect in K562 cells ...... geted to the bcr/abl oncogene.
@ast
Antigene effect in K562 cells ...... geted to the bcr/abl oncogene.
@en
P2093
P50
P356
P1433
P1476
Antigene effect in K562 cells ...... geted to the bcr/abl oncogene.
@en
P2093
Angela Risso
Franco Quadrifoglio
Gian Maria Bonora
Susanna Cogoi
P304
P356
10.1021/BI011314H
P407
P577
2002-01-01T00:00:00Z